Centiva Capital’s Sanofi SNY Stock Holding History

Centiva Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,700	Closed	-$636K	–	1797
2021 Q4	$636K	Buy	+12,700	New	+$628K	0.01%	733

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Centiva Capital's SNY Position: Q4 2025 in Review

Centiva Capital sold out of Sanofi (SNY) in Q4 2025, closing a stake of 12,537 shares — an estimated $592K sold.

Centiva Capital first reported a position in SNY in Q2 2023 and held it in 5 quarters. The position peaked at $1.01M in Q2 2025. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

Centiva Capital reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
Centiva Capital sold 12,537 Sanofi shares in Q4 2025, an estimated $592K.
Centiva Capital first reported a position in Sanofi in Q2 2023 and held it in 5 quarters.
Centiva Capital's Sanofi position peaked at $1.01M in Q2 2025.
757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.